Currently set to Index
Currently set to Follow
ask age2b

Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia

By AGE2B team
June 15, 2021

Main idea: MP-AzeFlu was superior to AZE in reducing moderate-to-severe seasonal allergic rhinitis symptoms, providing earlier and better symptom relief.


The novel intranasal formulation of azelastine hydrochloride (AZE) and fluticasone propionate (FP) in a single spray (MP-AzeFlu) was compared with a first-line intranasal antihistamine spray (AZE) in Russian seasonal allergic rhinitis (SAR) patients.

Moderate-to-severe allergic rhinitis and rhinoconjunctivitis patients (n = 149; aged 18-65 years) were randomized to receive MP-AzeFlu (137/50 μg AZE/FP per spray) or AZE (137 μg/spray), both as 1 spray per nostril twice daily, in a multi-center, open-label, 14-day, parallel-group trial.

Results: When compared with AZE spray-treated patients, those treated with MP-AzeFlu experienced significantly greater reductions in rhinitis and conjunctivitis symptoms. Superior relief observed on day 2 with MP-AzeFlu versus AZE was sustained throughout the study. MP-AzeFlu-treated patients experienced a greater improvement in the quality of life than AZE-treated. MP-AzeFlu spray was well tolerated.

Source Karger

Leave a Reply

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.